GlaxoSmithKline Bangladesh Ltd. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was BDT 1,430.058 million compared to BDT 1,606.916 million a year ago. Operating loss was BDT 687.443 million compared to operating Income of BDT 352.165 million a year ago. Net loss was BDT 585.908 million compared to net income of BDT 246.990 million a year ago. Basic loss per share was BDT 48.64 compared to basic earnings per share of BDT 20.5 a year ago. For the nine months, sales was BDT 4,807.396 million compared to BDT 4,969.152 million a year ago. Operating loss was BDT 462.202 million compared to operating Income of BDT 660.416 million a year ago. Net loss was BDT 403.516 million compared to net income of BDT 479.183 million a year ago. Basic loss per share was BDT 33.5 compared to basic earnings per share of BDT 39.78 a year ago.